Log in

Synergistic Activity of Trovafloxacin with Other Agents

  • Poster Presentations
  • Extended Abstract
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Eliopoulos GM, Klimm K, Eliopoulos CT, et al. In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrob Agents Chemother 1993; 37: 366–70

    Article  PubMed  CAS  Google Scholar 

  2. Spangler SK, Jacobs MR, Appelbaum PC. Activity of CP 99,219 combined with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob Agents Chemother 1994; 38: 2471–6

    Article  PubMed  CAS  Google Scholar 

  3. Child J, Andrews J, Boswell F, et al. The in-vitro activity of CP-99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. J Antimicrob Chemother 1995; 35: 869–76

    Article  PubMed  CAS  Google Scholar 

  4. Pankuch GA, Jacobs MR, Appelbaum PC. Activity of CP 99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 1995; 35: 230–2

    Article  PubMed  CAS  Google Scholar 

  5. Visalli MA, Bajaksouzian S, Jacobs MR, et al. Comparative activity of trovafloxacin alone and in combination with other agents, against gram-negative nonfermentative rods. Antimicrob Agents Chemother 1997; 41: 1475–81

    PubMed  CAS  Google Scholar 

  6. Bajaksouzian S, Visalli MA, Jacobs MR, et al. Activities of levofloxacin, ofloxacin and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob Agents Chemother 1997; 41: 1073–6

    PubMed  CAS  Google Scholar 

  7. Eliopoulos GM, Moellering Jr RC. Antimicrobial combinations. In: Lorian VA, editor. Antibiotics in laboratory medicine. Baltimore: Williams and Wilkins, 1996; 330–96

    Google Scholar 

  8. Teng R, Harris SC, Nix DE, et al. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. J Antimicrob Chemother 1995; 36: 385–94

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter C. Appelbaum.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Visalli, M.A., Bajaksouzian, S., Jacobs, M.R. et al. Synergistic Activity of Trovafloxacin with Other Agents. Drugs 58 (Suppl 2), 141–143 (1999). https://doi.org/10.2165/00003495-199958002-00036

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199958002-00036

Navigation